Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
33.33%
operating margin TTM
39.68%
revenue TTM
453.19 Million
revenue per share TTM
3.73$
valuation ratios | |
|---|---|
| pe ratio | 17.60 |
| peg ratio | 1.57 |
| price to book ratio | 3.97 |
| price to sales ratio | 5.94 |
| enterprise value multiple | 16.06 |
| price fair value | 3.97 |
profitability ratios | |
|---|---|
| gross profit margin | 84.1% |
| operating profit margin | 39.68% |
| pretax profit margin | 43.98% |
| net profit margin | 33.33% |
| return on assets | 19.25% |
| return on equity | 25.62% |
| return on capital employed | 26.7% |
liquidity ratio | |
|---|---|
| current ratio | 5.17 |
| quick ratio | 5.01 |
| cash ratio | 4.29 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 91.22 |
| operating cycle | 139.83 |
| days of payables outstanding | 77.46 |
| cash conversion cycle | 62.37 |
| receivables turnover | 7.51 |
| payables turnover | 4.71 |
| inventory turnover | 4.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.00 |
| debt equity ratio | 0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.00 |
| interest coverage | 0.00 |
| cash flow to debt ratio | 75.22 |
cash flow ratios | |
|---|---|
| free cash flow per share | 2.00 |
| cash per share | 4.32 |
| operating cash flow per share | 2.00 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | 75.22 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 431.31 |
Frequently Asked Questions
When was the last time Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) reported earnings?
Catalyst Pharmaceuticals, Inc. (CPRX) published its most recent earnings results on 06-11-2024.
What is Catalyst Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)'s trailing twelve months ROE is 25.62%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Catalyst Pharmaceuticals, Inc. (CPRX) currently has a ROA of 19.25%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did CPRX's net profit margin stand at?
CPRX reported a profit margin of 33.33% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is CPRX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 5.17 in the most recent quarter. The quick ratio stood at 5.01, with a Debt/Eq ratio of 0.00.